Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2153866013 | Bromazine hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2154888015 | Bromodiphenhydramine hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3491882011 | Bromazine hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bromazine hydrochloride | Is a | Product containing bromazine | false | Inferred relationship | Existential restriction modifier | ||
| Bromazine hydrochloride | Is a | Sedating antihistamine | false | Inferred relationship | Existential restriction modifier | ||
| Bromazine hydrochloride | Is a | Bromazine | false | Inferred relationship | Existential restriction modifier | ||
| Bromazine hydrochloride | Has disposition | Histamine receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Bromazine hydrochloride | Is modification of | Bromazine | true | Inferred relationship | Existential restriction modifier | ||
| Bromazine hydrochloride | Is a | Ethanolamine derivative with histamine receptor antagonist mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug) | Has basis of strength substance | True | Bromazine hydrochloride | Inferred relationship | Existential restriction modifier | 2 |
| Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug) | Has precise active ingredient | True | Bromazine hydrochloride | Inferred relationship | Existential restriction modifier | 2 |
This concept is not in any reference sets
FHIR